The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A

Ambre Jousselin(University Hospital of Geneva), Caroline Manzano(University Hospital of Geneva), Alexandra Biette(University Hospital of Geneva), Patricia Reed(Universidade Nova de Lisboa), Mariana G. Pinho(Universidade Nova de Lisboa), Adriana E. Rosato(Houston Methodist), William L. Kelley(University Hospital of Geneva), Adriana Renzoni(University Hospital of Geneva)
Antimicrobial Agents and Chemotherapy
December 29, 2015
Cited by 76Open Access
Full Text

Abstract

Expression of the methicillin-resistant S. aureus (MRSA) phenotype results from the expression of the extra penicillin-binding protein 2A (PBP2A), which is encoded by mecA and acquired horizontally on part of the SCCmec cassette. PBP2A can catalyze dd-transpeptidation of peptidoglycan (PG) because of its low affinity for β-lactam antibiotics and can functionally cooperate with the PBP2 transglycosylase in the biosynthesis of PG. Here, we focus upon the role of the membrane-bound PrsA foldase protein as a regulator of β-lactam resistance expression. Deletion of prsA altered oxacillin resistance in three different SCCmec backgrounds and, more importantly, caused a decrease in PBP2A membrane amounts without affecting mecA mRNA levels. The N- and C-terminal domains of PrsA were found to be critical features for PBP2A protein membrane levels and oxacillin resistance. We propose that PrsA has a role in posttranscriptional maturation of PBP2A, possibly in the export and/or folding of newly synthesized PBP2A. This additional level of control in the expression of the mecA-dependent MRSA phenotype constitutes an opportunity to expand the strategies to design anti-infective agents.


Related Papers

No related papers found

Powered by citation graph analysis